Expression of TGF-β at Different Stages of Hemangiomas: Correlation with Mast Cell

QIN Xing-jun,YUAN Wei-li,Wang Xu-kai
2009-01-01
Abstract:PURPOSE: To investigate the expression of TGF-β and its relationship with mast cell in the different stages of vessel differentiation in human dermal hemangiomas. METHODS: 56 cases of human dermal hemangioma specimen were collected. The evolutional process of hemangioma were divided into six stages, which were the early stage, intermediate stage and advanced stage of proliferating hemangioma and involuting hemangioma. Immunohistochemical staining technique(SABC) and toluidine blue (TB) staining were used to detect the expression of TGF-β and the number of mast cells in different stages of human dermal hemangioma; Micro-image analysis software was used to determine the mean value of mast cells, average positive area ratio of TGF-β in different stages of human dermal hemangioma. SPSS for Windows 11.0 software package was used to analyze the results by means of one -way ANNOVA,Student’s t test and Pearson correlation analysis. RESULTS: The number of mast cells increased gradually from the early stage of proliferating hemangioma to the advanced stage of proliferating hemangioma and decreased gradually from the early stage of involuting hemangioma to the advanced stage of involuting hemangioma. There was significant difference between the advanced stage of proliferating hemangioma and other stages of proliferating hemangioma in the number of mast cells (P0.01). There was also significant statistical difference between the early stage of involuting hemangioma and the other stages of involuting hemangioma in the number of mast cells (P0.01). The expression of TGF-β increased gradually from the early stage ofproliferating hemangioma to the advanced stage of proliferating hemangioma and decreased gradually from the early stage of involuting hemangioma to the advanced stage of involuting hemangioma. The expression of TGF-β in endothelial cells during the early stage of involuting hemangioma was significantly higher than the other stages in involuting hemangioma (P 0.01). The expression of TGF -β in endothelial cells during the advanced stage of proliferating hemangioma was significantly higher than the other stages in proliferating hemangioma (P 0.01). The expression level of TGF -β in endothelial cells was positively correlated with the number of mast cells in different stages of human dermal hemangioma (P0.01). CONCLUSIONS: With the natural evolutional process of hemangioma, the number of mast cells displays regular variation and mast cell may play a promotive role of apoptosis during the spontaneous involution of human dermal hemangioma; TGF -β may promote the apoptosis of vascular endothelial cells in hemangioma and furthermore the involutional process of hemangioma; Mast cells may produce TGF-β and promote the spontaneous involution of human dermal hemangioma.
What problem does this paper attempt to address?